Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells

Journal of General Virology

Volumn 88, Issue 1, 2007, Pages 46-50

  Xu, Yiyiang ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CXCL16 CHEMOKINE; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGENIC AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN NAP 2; RANTES; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; KAPOSI SARCOMA; LATENT VIRUS INFECTION; LYMPHOCYTE MIGRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SPINDLE CELL; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR GROWTH; UPREGULATION;

CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CXC; CYTOKINES; ENDOTHELIAL CELLS; HERPESVIRUS 8, HUMAN; HUMANS; RECEPTORS, SCAVENGER; SARCOMA, KAPOSI; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 33846140800     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82375-0     Document Type: Article

References (30)

1. An, J., Sun, Y., Sun, R. & Rettig, M. B. (2003). Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways. Oncogene 22, 3371-3385.
2. Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C. & Cesarman, E. (1997). Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347-350.
3. Boshoff, C., Schulz, T. F., Kennedy, M. M., Graham, A. K., Fisher, C., Thomas, A., McGee, J. O., Weiss, R. A. & O'Leary, J. J. (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1, 1274-1278.
4. Chaudhary, P. M., Jasmin, A., Eby, M. T. & Hood, L. (1999). Modulation of the NF-κB pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738-5746.
5. Ciufo, D. M., Cannon, J. S., Poole, L. J., Wu, F. Y., Murray, P., Ambinder, R. F. & Hayward, G. S. (2001). Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol 75, 5614-5626.
6. Ensoli, B. & Stürzl, M. (1998). Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9, 63-83.
7. Ensoli, B., Sgadari, C., Barillari, G., Sirianni, M. C., Stürzl, M. & Monini, P. (2001). Biology of Kaposi's sarcoma. Eur J Cancer 37, 1251-1269.
8. Field, N., Low, W., Daniels, M., Howell, S., Daviet, L., Boshoff, C. & Collins, M. (2003). KSHV vFLIP binds to IKK-γ to activate IKK. J Cell Sci 116, 3721-3728.
9. Glaunsinger, B. & Ganem, D. (2004). Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J Exp Med 200, 391-398.
10. Grossmann, C., Podgrabinska, S., Skobe, M. & Ganem, D. (2006). Activation of NF-κB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80, 7179-7185.
11. κB kinase complex. J Biol Chem 277, 13745-13751.
12. Ludwig, A., Hundhausen, C., Lambert, M. H., Broadway, N., Andrews, R. C., Bickett, D. M., Leesnitzer, M. A. & Becherer, J. D. (2005). Metalloproteinase inhibitors for the disintegrin-like metallo-proteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8, 161-171.
13. Maral, T. (2000). The Koebner phenomenon in immunosuppression-related Kaposi's sarcoma. Ann Plast Surg 44, 646-648.
14. Matloubian, M., David, A., Engel, S., Ryan, J. E. & Cyster, J. G. (2000). A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1, 298-304.
15. Matta, H. & Chaudhary, P. M. (2004). Activation of alternative NT-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A 101, 9399-9404.
16. Moore, P. S., Boshoff, C., Weiss, R. A. & Chang, Y. (1996). Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744.
17. + T cells. Science 242, 426-430.
18. Nicholas, J. (2005). Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 25, 373-383.
19. Nicholas, J., Ruvolo, V. R., Burns, W. H., Sandford, G., Wan, X., Ciufo, D., Hendrickson, S. B., Guo, H.-G., Hayward, G. S. & Reitz, M. S. (1997). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3, 287-292.
20. Oksenhendler, E., Carcelain, G., Aoki, Y., Boulanger, E., Maillard, A., Clauvel, J.-P. & Agbalika, F. (2000). High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 96, 2069-2073.
21. Parravicini, C., Chandran, B., Corbellino, M., Berti, E., Paulli, M., Moore, P. S. & Chang, Y. (2000). Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156, 743-749.
22. Schulz, T. F. (1999). Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res 76, 121-160.
23. Staskus, K. A., Sun, R., Miller, G., Racz, P., Jaslowski, A., Metroka, C., Brett-Smith, H. & Haase, A. T. (1999). Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73, 4181-4187.
24. Sun, Q., Matta, H. & Chaudhary, P. M. (2003a). The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-κB activation. Blood 101, 1956-1961.
25. Sun, Q., Zachariah, S. & Chaudhary, P. M. (2003b). The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-κB activation. J Biol Chem 278, 52437-52445.
26. Sun, Q., Matta, H. & Chaudhary, P. M. (2005). Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 long terminal repeat via the classical NF-κB pathway and functionally cooperates with Tat. Retrovirology 2, 9.
27. Sun, Q., Matta, H., Lu, G. & Chaudhary, P. M. (2006). Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-κB activation. Oncogene 25, 2717-2726.
28. Wang, H.-W., Trotter, M. W. B., Lagos, D., Bourboulia, D., Henderson, S., Mäkinen, T., Elliman, S., Flanagan, A. M., Alitalo, K. & Boshoff, C. (2004). Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36, 687-693.
29. Zhou, F.-C., Zhang, Y.-J., Deng, J.-H., Wang, X.-P., Pan, H.-Y., Hettler, E. & Gao, S.-J. (2002). Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76, 6185-6196.
30. Zhuge, X., Murayama, T., Arai, H., Yamauchi, R., Tanaka, M., Shimaoka, T., Yonehara, S., Kume, N., Yokode, M. & Kita, T. (2005). CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells. Biochem Biophys Res Commun 331, 1295-1300.